To Company Name/Scheme ACN/ARSN 1. Details of substantial holder (1) Name ACN/ARSN (if applicable) - 19/08/2026 The previous notice was given to the company on 19/03/2026 The previous notice was dated 17/03/2026 2. Previous and present voting power *The % substantial is based on...
Change in substantial holding
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Change in substantial shareholding for OSL
- Application for quotation of securities - OSL
- Investor Webinar Presentation
- OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from OncoSil Medical
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- OncoSil submits US Reimbursement Application
- OncoSil submits US Reimbursement Application (Updated)
- Proposed issue of securities - OSL
